Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT02312700UnknownBreast Cancer | Empowerment
-
NCT01908270CompletedBreast Cancer | Menopause
-
NCT00019643TerminatedDepression | Quality of Life | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Nutrition | Psychosocial Effects/Treatment
-
NCT06450873RecruitingHER2-Negative Breast Carcinoma | Estrogen Receptor-Positive Breast Carcinoma
-
NCT00877500Active, not recruitingInvasive Breast Carcinoma | HER2/Neu Negative | Bilateral Breast Carcinoma
-
NCT03109080CompletedRadiotherapy Side Effect | Breast Neoplasm Malignant Female | Breast Neoplasms, Triple-Negative
-
NCT00001507CompletedNeoplasm Metastasis | Breast Neoplasm
-
NCT07153757Not yet recruitingBreast Cancer Early Stage Breast Cancer (Stage 1-3)
-
NCT07152782Not yet recruitingHER2-positive Breast Cancer | Breast Cancer With Brain Metastasis
-
NCT07042737Not yet recruitingMotivation | Menopausal Women | Breast Cancer Females | Screening Strategy | Education Nursing
-
-
NCT06832202RecruitingHER2-low Hormone Receptor Positive Breast Cancer
-
NCT05560308Not yet recruitingHER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
-
NCT04986579RecruitingMetastatic Breast Cancer | Chemotherapy-induced Alopecia
-
NCT04911699Not yet recruitingSymptom Distress During Breast Cancer Treatment
-
NCT04546009Active, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
-
NCT04576455Active, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
-
NCT01996046Active, not recruitingBone Metastases | Estrogen Receptor Positive Breast Cancer
-
NCT05716542CompletedBreast Cancer | Cancer of the Breast
-
NCT03407768CompletedBreast Cancer | Hormone Receptor Positive Tumor | Premenopausal Breast Cancer
-
NCT05149014CompletedHER2-positive Breast Cancer
-
-
NCT03612934CompletedQuality of Life | Breast Cancer | Palliative Care | Cancer, Breast
-
NCT02393105UnknownCarcinoma of Male Breast
-
NCT07415200Not yet recruitingPostoperative Complications | Breast Cancer | Breast Cancer-Related Lymphedema
-
NCT06507033Not yet recruitingBreast Cancer Related Lymphedema
-
NCT06347068RecruitingBreast Cancer | Triple Negative Breast Cancer | Relapse | Resistant Cancer
-
NCT05601037RecruitingLymphedema, Breast Cancer
-
NCT05455619RecruitingMetastatic Breast Cancer | HR+/HER2-negative Breast Cancer
-
NCT04579029RecruitingBreast Cancer | Lymphedema
-
NCT04446494RecruitingBreast Cancer Related Lymphedema
-
NCT04328610Recruiting
-
-
NCT07132749Enrolling by invitationNEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd (PRO-NEPA)Patients With HER2-positive Advanced Breast Cancer Treated With T-DXd | Patients With HER2-low Advanced Breast Cancer Treated With T-DXd
-
NCT07072780Completed
-
NCT04465253Completed
-
NCT02983071Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, Breast
-
NCT02806817CompletedBreast Cancer | Early-Stage Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
-
NCT03534570UnknownHeart Diseases | Breast Neoplasm Female | Radiotherapy Side Effect
-
NCT02726477UnknownBreast Cancer | Lymphedema
-
NCT01672125Unknown
-
NCT07373782RecruitingBreast Cancer Early Stage Breast Cancer (Stage 1-3)
-
NCT07133087Recruiting
-
NCT07049133RecruitingToxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer (Tox-DXd)Metastatic Breast Cancer
-
NCT05662345Active, not recruitingMetastatic Breast Cancer
-
NCT06057610Active, not recruitingHER2-PositiveRecurrent or Metastatic Breast Cancer
-
NCT05280067CompletedMetastatic Breast Cancer in the Spine
-
NCT07032220Active, not recruitingNeoadjuvant Therapy | Breast Cancer Surgery | Sentinel Lymph Node Biopsy (SLNB)
-
NCT02102568Completed
-
NCT04116151CompletedDERMATITIS INDUCED BY RADIOTHERAPY IN PATIENTS WHITH BREAST CANCER
-
NCT04822597CompletedBreast Cancer | Breast Neoplasms | Sentinel Lymph Node | Breast Cancer Female